Remote behaviour change service for inactive adults with lung disease: A non-randomised controlled study
Chronic Respiratory Disease · 2026-06 · 23
DOI: 10.1177/14799731261453571 ↗Kurz gefasst
Kontrollierte klinische Studie in der Zeitschrift Chronic Respiratory Disease, online erschienen am 01.06.2026. Verfasst von Jones Aw und 12 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory Research@Alfred, Monash University, Melbourne, Australia. Hauptthemen laut MEDLINE: Exercise, Health Behavior, Sedentary Behavior, Lung Diseases. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Sport England and the British Lung Foundation, British Lung Foundation, Sport England.
Abstract (Originalsprache)
Objectives
To determine whether a remote behaviour change service (Active Steps), delivered by a UK charity, can increase physical activity over a 12-month period in adults with lung disease.
Methods
Active Steps (n=166) consisted of 1:1 telephone health coaching for 12 months alongside printed (e.g. activity diary and chart, information and goal setting booklet) and digital behaviour change strategies (e.g. exercise videos, motivational newsletters, pedometer). A concurrent control group was recruited (n=80) for comparison. Self-reported physical activity (Short Active Lives Survey) and self-reported health (EQ-VAS) were collected at baseline, 3, 6, and 12 months. Logistic regression models (adjusted for confounders) were used to analyse the odds of becoming physically active or average changes in physical activity time and EQ-VAS.
Results
Primary outcome : The number of participants defined as physically active at 12 months was greater with Active Steps (46%) compared to controls (23%) which was statistically significant in an unadjusted (odds ratio (OR) [95% confidence intervals (CI)]:2.8 [1.3-6.1], p=0.011) but not adjusted model (OR: 2.2 [0.9-5.4], p=0.097). Secondary outcomes : Compared to controls, Active Steps increased the number of participants physically active at 3 and 6 months, increased the weekly minutes of moderate-vigorous physical activity and improved self-reported health (EQ-VAS) across all timepoints.
Discussion
Our findings suggest that charity-led remote behaviour change support is effective in the short-to-medium-term in adults with lung disease, but high participant attrition necessitates caution in interpreting sustained effect estimates at 12 months. Further long-term evaluations are needed to address adherence and sustainability of such services.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Respiratory Research@Alfred, Monash University, Melbourne, Australia.
- Lincoln International Institute for Rural Health, University of Lincoln, Lincoln, UK.
- Patient and Public Contributor, University of Lincoln, Lincoln, UK.
- Community and Health Research Unit, University of Lincoln, Lincoln, UK.
- Clarach Economics, Ceredigion, UK.
- Asthma + Lung UK, London, UK.
Förderung
- Sport England and the British Lung Foundation
- British Lung Foundation
- Sport England
Zitieren
APA
Aw, J., H, R., M, S., A, B., C, R., M, S., J, P., J, S., C, W., A, D., M, H., An, S., & G, L. (2026). Remote behaviour change service for inactive adults with lung disease: A non-randomised controlled study. Chronic Respiratory Disease, 23. https://doi.org/10.1177/14799731261453571
Vancouver
Aw J, H R, M S, A B, C R, M S, et al. Remote behaviour change service for inactive adults with lung disease: A non-randomised controlled study. Chronic Respiratory Disease. 2026;23. doi:10.1177/14799731261453571
BibTeX
@article{Aw2026,
author = {Aw, Jones and H, Robinson and M, Saunders and A, Brewster and C, Ridyard and M, Smith and J, Peel and J, Shopland and C, Wilson and A, Dean and M, Hinchliffe and An, Siriwardena and G, Law},
title = {Remote behaviour change service for inactive adults with lung disease: A non-randomised controlled study},
journal = {Chronic Respiratory Disease},
year = {2026},
volume = {23},
doi = {10.1177/14799731261453571}
}
EUVIMED